Safety Assessment of 10-Day Daily Bucco-Oral Administration of Transfer Factor in Healthy Adult Human Subjects

2024-511448-17-02 Protocol CPA 556-24 Human pharmacology (Phase I) - First administration to humans Ended

Start 16 Oct 2024 · End 18 Nov 2024 · Status Ended · 1 EU/EEA countries · 1 sites · Protocol CPA 556-24

Overview

Sponsor-declared trial summary

Phase Human pharmacology (Phase I) - First administration to humans
Status Ended
Participants planned 16
Countries 1
Sites 1

healthy subjects

Key facts

Sponsor
Cepha s.r.o., Aumed a.s.
Participant type
Healthy volunteers
Age range
18-64 years
Gender
Male and Female
Therapeutic area
Diseases [C] - Immune System Diseases [C20]
Trial duration
16 Oct 2024 → 18 Nov 2024
Decision date (initial)
2024-10-15
Transition trial
No
Low-intervention
No
Rare-disease indication
No
Vulnerable population
No

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

healthy subjects

VersionLevelCodeTermSystem organ class
20.1 LLT 10000566 Acquired immunodeficiency syndrome unspecified 10021881

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

Cepha s.r.o.

Sponsor organisation
Cepha s.r.o.
Address
Komenskeho 19, Severni Predmesti Severni Predmesti
City
Plzen 1
Postcode
323 00
Country
Czechia

Scientific contact point

Organisation
Aumed a.s.
Contact name
Juraj Vronka

Public contact point

Organisation
Aumed a.s.
Contact name
Juraj Vronka

Aumed a.s.

Sponsor organisation
Aumed a.s.
Address
Komoranska 326/63, Modrany Modrany
City
Prague
Postcode
143 00
Country
Czechia

Scientific contact point

Organisation
Aumed a.s.
Contact name
Juraj Vronka

Public contact point

Organisation
Aumed a.s.
Contact name
Juraj Vronka

Locations

1 EU/EEA country · 1 investigational sites

By country

CountryMS statusPlanned subjectsSites
Czechia Ended 16 1
Rest of world 0

Investigational sites

Czechia

1 site · Ended
Cepha s.r.o.
clinic, Komenskeho 19, Severni Predmesti, Plzen 1

Country notifications

Trial-start, recruitment-start, end and early-termination notifications submitted per Member State

Country Trial startTrial end Recruitment startRecruitment end Early termination
Czechia 2024-10-16 2024-11-18 2024-10-16 2024-10-29

Application history

1 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2024-08-27 Czechia Acceptable
2024-10-15
2024-10-15